MEDICAL COLLEGE OF WISCONSIN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1893-01-01

Employees: 5K

Market Cap: -

Website: http://www.mcw.edu

Clinical Trials

Pectointercostal Fascial Plane Block (PIFB) Alone Versus PIFB with Rectus Sheath Block (RSB) in Cardiac Surgery

Phase 1

Completed

Conditions: Postoperative Pain
Respiratory Failure
Coronary Artery Disease

Interventions: Drug: Rectus sheath block with bupivacaine

First Posted Date: 2021-06-01

Last Posted Date: 2024-11-18

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 62

Registration Number: NCT04908449

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold)

Terminated

Conditions: Covid19

Interventions: Device: COVID-19 SARS-CoV IgG/IgM antibody rapid test

First Posted Date: 2021-05-26

Last Posted Date: 2024-01-08

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 91

Registration Number: NCT04902911

Locations: 🇺🇸
Froedtert Health WAC, Wauwatosa, Wisconsin, United States

Distracting Through Procedural Pain and Distress

Not Applicable

Completed

Conditions: Sickle Cell Disease
Chronic Illness
Hematologic Malignancy
Bone Marrow Transplant Infection
Oncology

Interventions: Other: Guided Imagery
Other: Virtual Reality

First Posted Date: 2021-05-19

Last Posted Date: 2021-05-19

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 67

Registration Number: NCT04892160

Locations: 🇺🇸
Children's Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸
Medical College of Wisconsin, Wauwatosa, Wisconsin, United States

Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors

Recruiting

Conditions: Hematopoietic and Lymphoid Cell Neoplasm

Interventions: Procedure: Biospecimen Collection
Other: Electronic Health Record Review
Other: Questionnaire Administration

First Posted Date: 2021-05-19

Last Posted Date: 2023-08-01

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 110

Registration Number: NCT04892823

Locations: 🇺🇸
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Behavioral: IMB

First Posted Date: 2021-04-29

Last Posted Date: 2024-12-11

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 118

Registration Number: NCT04865341

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Effect of Presenting Survival Information as Text or Pictograph During Periviable Birth Counseling

Not Applicable

Completed

Conditions: Premature Birth

Interventions: Behavioral: Format of outcome data presentation
Behavioral: Displayed chance of survival

First Posted Date: 2021-04-26

Last Posted Date: 2023-11-24

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 1052

Registration Number: NCT04859114

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Phase 2

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Isatuximab (for run-in portion)
Drug: Isatuximab (for expansion)
Drug: Pomalidomide
Drug: Elotuzumab
Drug: Dexamethasone

First Posted Date: 2021-04-08

Last Posted Date: 2024-02-07

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 53

Registration Number: NCT04835129

Locations: 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Protocol Number: HJKC3-0003. Treatment Free Remission After Combination Therapy With Asciminib (ABL001) Plus Tyrosine Kinase Inhibitors (TKI) in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Phase 2

Recruiting

Conditions: Chronic Phase Chronic Myelogenous Leukemia

Interventions: Drug: Asciminib 40 MG
Drug: Asciminib 40 MG Twice Daily
Drug: Asciminib 80 MG daily
Drug: Imatinib
Drug: Dasatinib
Drug: Nilotinib

First Posted Date: 2021-04-08

Last Posted Date: 2024-04-03

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 51

Registration Number: NCT04838041

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇺🇸
The Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

and more 1 locations

Intervention to Improve Diabetes Outcomes in Older African American Women With Multi-Caregiving Burden

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Behavioral: Diabetes Enhanced Usual Care Intervention
Behavioral: Multi-Caregiving Intervention

First Posted Date: 2021-04-05

Last Posted Date: 2024-10-01

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 60

Registration Number: NCT04831697

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

Phase 1

Recruiting

Conditions: Rectal Adenocarcinoma

Interventions: Drug: Capecitabine
Device: Initial Dose of Radiation before Dose Escalation
Drug: FOLFOX

First Posted Date: 2021-03-22

Last Posted Date: 2024-02-13

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 22

Registration Number: NCT04808323

Locations: 🇺🇸
Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy